Analysis of 4-year Dutch reimbursement application data of biological therapies for psoriatic arthritis.

Objectives: To get the approval for reimbursement of biological therapies for PsA, patients need to fulfil specific criteria in many countries. The aim of this study was to evaluate the 4-year Dutch reimbursement application data, including the diagnostic, disease activity and response criteria that were applied for treatment of PsA with biologics.

Methods: All initial and follow-up applications for approval of treatment with biologics were included for investigation.